-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Wry8NFLhOtiH8PzfT75ltQNP5Td6UgjQprIFRwPveyvjgJLFZiMj8RDP31JCDlKx tbFf8xbrmf0rMo9bpjAm2g== 0001144204-05-028611.txt : 20050913 0001144204-05-028611.hdr.sgml : 20050913 20050913113708 ACCESSION NUMBER: 0001144204-05-028611 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050913 DATE AS OF CHANGE: 20050913 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Hana Biosciences Inc CENTRAL INDEX KEY: 0001140028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841588441 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79910 FILM NUMBER: 051081480 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 215 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6505886404 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BOULEVARD STREET 2: SUITE 215 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EMAIL REAL ESTATE COM INC DATE OF NAME CHANGE: 20010504 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: R R BIOTECH PARTNERS LLC CENTRAL INDEX KEY: 0001295249 IRS NUMBER: 260083392 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 330 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-356-0509 MAIL ADDRESS: STREET 1: 330 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G/A 1 v025573_sc13g-a.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - -------------------------------------------------------------------------------- SCHEDULE 13G (RULE 13d-1) Amendment Number 1 INFORMATION STATEMENTS PURSUANT TO RULE 13d-1 and 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 - -------------------------------------------------------------------------------- HANA BIOSCIENCES, INC. ---------------------- (Name of Issuer) COMMON STOCK ------------ (Title of Class of Securities) 40963P105 --------- (CUSIP Number) September 12, 2005 ------------------ (Date of event which requires filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) (Continued on following pages) Page 2 of 4 - ------- ------------------------------------------------------------------------ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON R&R Biotech Partners, LLC - ------- ------------------------------------------------------------------------ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------- ------------------------------------------------------------------------ 3. SEC USE ONLY - ------- ------------------------------------------------------------------------ 4. CITIZENSHIP OR PLACE OF ORGANIZATION: - ------- ------------------------------------------------------------------------ NUMBER OF SHARES 5. SOLE VOTING POWER BENEFICIALLY OWNED BY 903,282 EACH REPORTING PERSON WITH - ------------------------- ---- ------------------------------------------------- 6. SHARED VOTING POWER 0 - ------------------------- ---- ------------------------------------------------- 7. SOLE DISPOSITIVE POWER 903,282 - ------------------------- ---- ------------------------------------------------- 8. SHARED DISPOSITIVE POWER 0 - ------------------------- ---- ------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4.9% - -------- ----------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] - -------- ----------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.9% - -------- ----------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: PN - -------- ----------------------------------------------------------------------- Page 3 of 4 Item 1(a). Name of Issuer. Hana Biosciences, Inc. Item 1(b). Address of Issuer's Principal Executive Offices. 400 Oyster Point Boulevard, Suite 215, South San Francisco, CA 94080. Item 2(a). Name of Person Filing. R&R Biotech Partners, LLC. Item 2(b). Address of Principal Business Office, or if none, Residence. 1270 Avenue of the Americas 16th Floor, New York, NY 10020. Item 2(c). Citizenship. Delaware. Item 2(d). Title of Class of Securities. Common Stock. Item 2(e). CUSIP Number. 40963P105 Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check whether the person filing is a: Not applicable. Item 4. Ownership. The information contained in Items 5 though 11 on the cover pages hereto is incorporated herein by reference. The Reporting Person has the sole power to vote or dispose of the 903,282 shares beneficially owned by it. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction which could have that purpose or effect. Page 4 of 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 12, 2005 R&R BIOTECH PARTNERS, LLC By: /s/ Thomas Pinou Name: Thomas Pinou Title: Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----